Citations 6

Hyperorality in Frontotemporal Dementia: How Psychiatric and Neural Correlates Change During the Disease Course

The Journal of Neuropsychiatry and Clinical Neurosciences | March 26, 2025 | Volume: 38 | Issue: 1 | Pages: 31-37

10.1176/appi.neuropsych.20240134 | PMID 40134270

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

Journal of Alzheimer's Disease | January 6, 2017 | Volume: 56 | Issue: 3 | Pages: 929-938

10.3233/jad-160979 | PMID 28059789

O1‐13‐03: The Mild Behavioral Impairment Checklist (MBI‐C): a New Rating Scale for Neuropsychiatric Symptoms as Early Manifestations of Neurodegenerative Disease

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2016.06.366

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

Alzheimer's & Dementia | June 18, 2015 | Volume: 12 | Issue: 2 | Pages: 195-202

10.1016/j.jalz.2015.05.017 | PMID 26096665

Abstract Neuropsychiatric symptoms (NPS) are common in dementia and in predementia syndromes such as mild cognitive impairment (MCI). NPS in MCI confer a greater risk for conversion to dementia in comparison to MCI patients without NPS. NPS in older adults with normal cognition also confers a greater risk of cognitive decline in comparison to older adults without NPS. Mild behavioral impairment (MBI) has been proposed as a diagnostic construct aimed to identify patients with an increased risk of developing dementia, but who may or may not have cognitive symptoms. We propose criteria that include MCI in the MBI framework, in contrast to prior definitions of MBI. Although MBI and MCI can co‐occur, we suggest that they are different and that both portend a higher risk of dementia. These MBI criteria extend the previous literature in this area and will serve as a template for validation of the MBI construct from epidemiologic, neurobiological, treatment, and prevention perspectives.
Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

Alzheimer's & Dementia | April 4, 2013 | Volume: 9 | Issue: 5 | Pages: 602-608

10.1016/j.jalz.2012.12.001 | PMID 23562430

Abstract Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are widespread and disabling. This has been known since Dr. Alois Alzheimer's first case, Frau Auguste D., presented with emotional distress and delusions of infidelity/excessive jealousy, followed by cognitive symptoms. Being cognizant of this, in 2010 the Alzheimer's Association convened a research roundtable on the topic of NPS in AD. A major outcome of the roundtable was the founding of a Professional Interest Area (PIA) within the International Society to Advance Alzheimer's Research and Treatment (ISTAART). The NPS‐PIA has prepared a series of documents that are intended to summarize the literature and provide more detailed specific recommendations for NPS research. This overview paper is the first of these living documents that will be updated periodically as the science advances. The overview is followed by syndrome‐specific synthetic reviews and recommendations prepared by NPS‐PIA workgroups on depression, apathy, sleep, agitation, and psychosis.
Diffusion Tensor Imaging Atlas-Based Analyses in Major Depression After Mild Traumatic Brain Injury

The Journal of Neuropsychiatry and Clinical Neurosciences | February 8, 2013 | Volume: 24 | Issue: 3 | Pages: 309-315

10.1176/appi.neuropsych.11080188 | PMID 23037644